News

The future of cancer treatment is ‘personalized’ mRNA vaccines. Experts fear RFK research cuts will jeopardize that
Scientists have discovered the ability to “personalize” cancer treatments using cutting-edge genetic technology - but experts ...
Vaccinating young children against Covid-19 may be more challenging this respiratory virus season
Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...
Are mRNA Vaccines Safe — and Should You Still Get a COVID Shot? Doctors on the Pros and Cons
RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...
HHS phases out mRNA vaccine trials for COVID-19, bird flu
The Trump administration on Tuesday eliminated 22 mRNA vaccine development projects for COVID-19 and bird flu, a stark shift ...
PharmTech50m
BARDA Pulls Plug on Vaxart Oral COVID Vaccine Trial After mRNA Rollback
The company is not developing an mRNA vaccine, but had been using one as the control in a 10,000-subject Phase IIb trial.
Considerable on MSN4d
mRNA Technology Expands Beyond COVID to Target Cancer and Cystic Fibrosis
Nobel Prize-winning mRNA technology, which saved millions of lives during the COVID-19 pandemic through vaccines, is now ...
Pulmonology Advisor7h
COVID-19 mRNA Vaccine Targeting Omicron JN.1 Lineage Safe
Vaccination with the updated COVID-19 mRNA vaccine containing the SARS-CoV-2 Omicron JN.1 lineage was not associated with an increased risk for 29 adverse events.
Jay Bhattacharya: Why the NIH is pivoting away from mRNA vaccines
Jay Bhattacharya is director of the National Institutes of Health.
STAT1d
NIH director: mRNA vaccine contracts were canceled because public lacks trust in technology
NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...